Trending...
- Uk Financial Ltd Featured In New York Business Now — 2019 Gold-Backed Bitcoin Prediction Now Becomes SEC Security Token Filing
- The Patina Collective & Artist Jesse Draxler Debut "The Machine of Loving Grace"
- Australian Aboriginal Cultural Immersions and First Nations Workshops
TEMECULA, Calif. - DelhiScan -- NATCO proudly announces that the United States Patent and Trademark Office (USPTO) has officially granted U.S. Patent No. 12,453,363 B2 for its latest invention, Persimonal®, a proprietary technology for preparing persimmon leaf extract.
This milestone patent underscores NATCO's commitment to advancing botanical science and delivering innovative, clinically relevant solutions in natural health and nutrition. Persimonal® represents a novel approach to harnessing the bioactive compounds of persimmon leaves, long valued in traditional medicine for their antioxidant, anti-inflammatory, and cardiovascular-supportive properties.
Key Highlights of Persimonal®
Executive Statement
More on Delhi Scan
"The awarding of this U.S. patent validates NATCO's dedication to scientific excellence and innovation in natural product development," said [Abdul Alkayali], [Executive Vice President] at NATCO. "Persimonal® is more than an extraction method—it's a platform for unlocking the full potential of persimmon leaves to support human health."
About NATCO
NATCO is a leader in natural product innovation, specializing in proprietary technologies that transform traditional botanicals into clinically relevant, market-ready solutions. With a focus on science, sustainability, and consumer wellness, NATCO continues to pioneer advancements that set new standards in the nutraceutical industry.
www.natcohealthyliving.com
This milestone patent underscores NATCO's commitment to advancing botanical science and delivering innovative, clinically relevant solutions in natural health and nutrition. Persimonal® represents a novel approach to harnessing the bioactive compounds of persimmon leaves, long valued in traditional medicine for their antioxidant, anti-inflammatory, and cardiovascular-supportive properties.
Key Highlights of Persimonal®
- Patent Protection: U.S. Patent No. 12,453,363 B2 secures NATCO's proprietary process for preparing persimmon leaf extract.
- Scientific Innovation: Persimonal® optimizes extraction to preserve and enhance the potency of polyphenols, flavonoids, and other beneficial compounds.
- Health Potential: Persimmon leaf extract has been studied for supporting vascular health, lowering blood pressure and cholesterol, metabolic balance, and overall wellness.
- Market Differentiation: Persimonal® positions NATCO at the forefront of botanical innovation, offering a unique, patent-backed ingredient for nutraceutical and functional food applications.
Executive Statement
More on Delhi Scan
- Heritage at South Brunswick's Resort-Style Amenities for Any Age and Every Lifestyle
- T-TECH Partners with Japan USA Precision Tools for 2026 US Market Development of the New T-TECH 5-Axis QUICK MILL™
- Record Revenues, Debt-Free Momentum & Shareholder Dividend Ignite Investor Attention Ahead of 2026–2027 Growth Targets: IQSTEL (N A S D A Q: IQST)
- New YouTube Channel Pair Launches to Bring Entertainment Nostalgia Back to Life
- BRAG Hosts Holiday Benefit — Awards 10 Student Scholarships & Honors Timberland with the Corporate Impact Award
"The awarding of this U.S. patent validates NATCO's dedication to scientific excellence and innovation in natural product development," said [Abdul Alkayali], [Executive Vice President] at NATCO. "Persimonal® is more than an extraction method—it's a platform for unlocking the full potential of persimmon leaves to support human health."
About NATCO
NATCO is a leader in natural product innovation, specializing in proprietary technologies that transform traditional botanicals into clinically relevant, market-ready solutions. With a focus on science, sustainability, and consumer wellness, NATCO continues to pioneer advancements that set new standards in the nutraceutical industry.
www.natcohealthyliving.com
Source: NATCO, Inc
0 Comments
Latest on Delhi Scan
- $80M+ Backlog as Florida Statewide Contract, Federal Wins, and Strategic Alliance Fuel Next Phase of AI-Driven Cybersecurity Growth: Cycurion $CYCU
- High-Conviction CNS Disruptor Aiming to Transform Suicidal Depression, Ketamine Therapeutics, and TMS - Reaching Millions by 2030
- Top10Christmas.co.uk Releases the UK Christmas Toy Trends 2025 Report
- Talagat Business Academy Announces Joint Certificate Program With The University of Chicago Booth School of Business
- LocaXion and Asseco CEIT Announce First-to-Market RTLS-Driven Digital Twin Platform for Healthcare, Manufacturing, and Logistics
- Slotozilla Launches New Report on How AI Is Reshaping Careers and Society
- OKAVA Pharmaceuticals Announces First Cat Dosed in MEOW-1 Study of OKV-119, the World's First Clinical-Stage GLP-1 Weight-Loss Therapy for Pets
- Explosive Growth in U.S. Cryptocurrency Cloud Mining Sets The Stage for New Platform Launch with Daily Rewards in a Transparent Revenue-Share Model
- Qtex Cierra Ronda de $7 Millones para Estandarizar la Banca Transfronteriza en los Mercados Emergentes de Latinoamérica
- America's Most Festive Garages Wanted for Garage.com's 2025 Holiday Contest
- FDA Accepts ANDA for KETAFREE™ as Analyst Sets $34 Price Target for NRx Pharmaceuticals: (N A S D A Q : NRXP) NRx is Poised for a massive Breakthrough
- BEC Technologies Expands MX-220 5G Industrial Router Series for Edge Connectivity
- "Latino Leaders Speak: Personal Stories of Struggle and Triumph, Volume II" Documents the Truth About Latino Excellence and Impact on American Society
- Broadway Smile Boutique Unveils Modern Website for Enhanced Patient Experience
- Fenix Consulting Group Expands Orange County Office to Meet Growing Client Demand
- Signature Smiles Dental Group Unveils New User-Friendly Website
- CCHR: New Data Shows Millions of U.S. Children Caught in Escalating Psychiatric Polypharmacy
- QwickContractReview.com Launches $19 Contract Review Service to Protect Consumers from Hidden Contract Risks
- 100% Bonus Depreciation Places New Spotlight on Off The Hook Yacht Sales Inc. (N Y S E: OTH) as a Major Player in the $57 Billion U.S. Marine Market
- CNCPW Benchmarks Global Industry Standards: Integrating SEC Compliance with 3 Million TPS Architecture for Institutional Infrastructure
